Pegcetacoplan structure
|
Common Name | Pegcetacoplan | ||
---|---|---|---|---|
CAS Number | 2019171-69-6 | Molecular Weight | N/A | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | (C2H4O)nC170H248N50O47S4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of PegcetacoplanPegcetacoplan is a pegylated complement C3 inhibitor peptide. Pegcetacoplan acts effect by binding with complement component 3 (C3) and its activation fragment C3b. Pegcetacoplan can be used for the research of complement-mediated diseases, including age-related macular degeneration, C3 glomerulopathy, Geographic atrophy (GA) and autoimmune haemolytic anaemia[1][2]. |
Name | Pegcetacoplan |
---|
Description | Pegcetacoplan is a pegylated complement C3 inhibitor peptide. Pegcetacoplan acts effect by binding with complement component 3 (C3) and its activation fragment C3b. Pegcetacoplan can be used for the research of complement-mediated diseases, including age-related macular degeneration, C3 glomerulopathy, Geographic atrophy (GA) and autoimmune haemolytic anaemia[1][2]. |
---|---|
Related Catalog |
Molecular Formula | (C2H4O)nC170H248N50O47S4 |
---|